Skip to Main Content

Author Details

Zhiqiang An
Zhengzhou University
1992
202
50
PMIDPaper TitleJournal TitlePublished Year
36411391A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins.Nat Chem Biol2023
38078382An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV.Emerg Microbes Infect2023
37992151Hyperleptinemia contributes to antipsychotic drug-associated obesity and metabolic disorders.Sci Transl Med2023
37816743Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection.NPJ Vaccines2023
37460548A polycistronic system for multiplexed and precalibrated expression of multigene pathways in fungi.Nat Commun2023
37141208Advances in the treatment of invasive fungal disease.PLoS Pathog2023
37103129Parasitization of <i>Aphis gossypii</i> Glover by <i>Binodoxys communis</i> Gahan Causes Shifts in the Ovarian Bacterial Microbiota.Insects2023
37100807Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.Nat Commun2023
37328286A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer.J Immunother Cancer2023
36696925Endotrophin neutralization through targeted antibody treatment protects from renal fibrosis in a podocyte ablation model.Mol Metab2023
36762937Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets.Expert Opin Investig Drugs2023
34818667The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.Nature2022
35550680Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.Cell Rep2022
35677079Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPins.bioRxiv2022
35476216Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.BioDrugs2022
35793453An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates.Mol Cancer Ther2022
35425350Homogeneous antibody-angiopep 2 conjugates for effective brain targeting.RSC Adv2022
35717259LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions.Mol Neurodegener2022
35388745Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse model.MAbs2022
36540309Engineering antibody and protein therapeutics to cross the blood-brain barrier.Antib Ther2022
36683763A novel humanized Chi3l1 blocking antibody attenuates acetaminophen-induced liver injury in mice.Antib Ther2022
36525420Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma.PLoS One2022
36522785The challenges and opportunities of scRNA-seq in COVID-19 research and clinical translation.Virol J2022
36211388Blocking LAIR1 signaling in immune cells inhibits tumor development.Front Immunol2022
36104515Impairment of IgG Fc functions promotes tumor progression and suppresses NK cell antitumor actions.Commun Biol2022
36070367A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease.Sci Transl Med2022
36138032Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth.Nat Commun2022
36034845Research progress and applications of nanobody in human infectious diseases.Front Pharmacol2022
36302510Antibody therapeutics for epithelial ovarian cancer.Expert Opin Biol Ther2022
35921534Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice.MAbs2022
36186370Correlation between dietary score and depression in cancer patients: Data from the 2005-2018 National Health and Nutrition Examination Surveys.Front Psychol2022
35132410Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth.bioRxiv2022
34952264Recent progress in development of monoclonal antibodies against human cytomegalovirus.Curr Opin Virol2022
35275718Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodies.Sci Adv2022
35338087Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy.J Immunother Cancer2022
35298903Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor.Cell Metab2022
32918786Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation.Cytometry B Clin Cytom2021
33795676Presence of complete murine viral genome sequences in patient-derived xenografts.Nat Commun2021
33494095Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.Nature2021
33682795Inhibition of astrocyte hemichannel improves recovery from spinal cord injury.JCI Insight2021
33904407Asprosin-neutralizing antibodies as a treatment for metabolic syndrome.Elife2021
33482584Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scope.Bioorg Med Chem2021
33758836The N501Y spike substitution enhances SARS-CoV-2 transmission.bioRxiv2021
33928233Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer.Antib Ther2021
33917421Human Endogenous Retroviruses in Glioblastoma Multiforme.Microorganisms2021
33556256Serum levels of endotrophin are associated with nonalcoholic steatohepatitis.Scand J Gastroenterol2021
35122056LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-κB signaling axis.Nat Cancer2021
34380633Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth.Cancer Res2021
34732895Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion.Nature2021
34462752Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.bioRxiv2021
  • 1 - 50 of 202

Recommended Authors

Zaid Taha
Ottawa Hospital Research Institute, University of Ottawa
Career Start Year 2018
Number of shared co-authors 0
Gen Li
Research Center for Nano-Biomaterials, Sichuan University
Career Start Year 2013
Number of shared co-authors 0
Bo Liu
Henan University
Career Start Year 2010
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Aaron M Ring
Yale University School of Medicine
Career Start Year 2006
Number of shared co-authors 0
James R Whittle
Walter and Eliza Hall Institute of Medical Research
Career Start Year 2006
Number of shared co-authors 2
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 1
Kang Li
Institute of Insect Science and Technology, South China Normal University
Career Start Year 2006
Number of shared co-authors 0
Ke Jin
West China Hospital, Sichuan University
Career Start Year 2005
Number of shared co-authors 0
Guan Wang
Jilin University
Career Start Year 2005
Number of shared co-authors 0
Dhiraj Kumar
Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Ho Min Kim
Center for Biomolecular and Cellular Structure, Institute for Basic Science (IBS)
Career Start Year 2003
Number of shared co-authors 0
Yi-Ting Wang
McGill Research Centre for Studies in Aging
Career Start Year 2003
Number of shared co-authors 0
Deng Pan
College of Plant Protection, Southwest University
Career Start Year 2001
Number of shared co-authors 0
Rong Fan
Institute of Pathogens and Vectors, Dali University
Career Start Year 1998
Number of shared co-authors 0
Bing-Hung Chen
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 0
Ji Eun Oh
College of Science & Industry Convergence, Ewha Womans University
Career Start Year 1997
Number of shared co-authors 0
Robert H Carnahan
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 4
Pavel Strop
Pfizer Inc.
Career Start Year 1997
Number of shared co-authors 0
Yunkai Yu
National Cancer Institute, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 0
Ranjini K Sundaram
Yale University
Career Start Year 1996
Number of shared co-authors 0
Ning Guo
Beijing Tongren Hospital, Capital Medical University
Career Start Year 1995
Number of shared co-authors 0
Yu-Tsueng Liu
University of California San Diego
Career Start Year 1994
Number of shared co-authors 0
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Bing Xia
Xijing Hospital, The Fourth Military Medical University
Career Start Year 1992
Number of shared co-authors 0
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Career Start Year 1992
Number of shared co-authors 6
Helena Persson
Lund University Cancer Centre
Career Start Year 1989
Number of shared co-authors 0
Sun Young Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1988
Number of shared co-authors 0
Jos?? Ignacio Casal
Max-Planck-Institut fur Entwicklungsbiologie
Career Start Year 1984
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0

Collaborators

Ningyan Zhang
Stem Cell Translational Research Center of Tongji Hospital, Tongji University
Co-authored papers 91
Vineet D Menachery
University of Texas Medical Branch
Co-authored papers 15
Pei-Yong Shi
University of Texas Medical Branch
Co-authored papers 15
Xuping Xie
University of Texas Medical Branch
Co-authored papers 15
Hang Su
Co-authored papers 9
Kenneth S Plante
University of Texas Medical Branch
Co-authored papers 8
Jessica A Plante
Co-authored papers 8
Hongjie Xia
University of Texas Medical Branch
Co-authored papers 8
Byung-Kwon Choi
Baylor College of Medicine
Co-authored papers 6
Zihao Yuan
Auburn University
Co-authored papers 6
Jason S McLellan
Co-authored papers 6
Alexander N Freiberg
University of Texas Medical Branch
Co-authored papers 6
Amy S Espeseth
Merck & Co., Inc.
Co-authored papers 6
Chisato Yamasaki
Osaka University
Co-authored papers 5
Anil K Sood
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers 3
Kalpit A Vora
Co-authored papers 3
Steven G Widen
University of Texas Medical Branch
Co-authored papers 3
Sally A Leong
USDA/ARS
Co-authored papers 3
Michael S Diamond
Washington University School of Medicine
Co-authored papers 3
Yize Li
Co-authored papers 2
Peter D Kwong
Co-authored papers 2
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Mehul S Suthar
Co-authored papers 2
Young Do Kwon
Co-authored papers 2
Robert H Collins
University of Texas Southwestern Medical Center
Co-authored papers 2
Wenjin Jim Zheng
University of Texas Health Science Center at Houston
Co-authored papers 2
Yaroslav Tsybovsky
Co-authored papers 2
Benhur Lee
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Lawrence Shapiro
Zuckerman Mind Brain Behaviour Institute
Co-authored papers 2
Release 1.2